These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Efficacy of non-toxic deletion mutants of protective antigen from Bacillus anthracis. Rhie GE; Park YM; Han JS; Yu JY; Seong WK; Oh HB FEMS Immunol Med Microbiol; 2005 Aug; 45(2):341-7. PubMed ID: 16019195 [TBL] [Abstract][Full Text] [Related]
11. [The isolation and purification of the protective antigen and the edema factor from the culture filtrate of Bacillus anthracis STI-1]. Rogov SN; Beznosov MV; Chugaĭ VL; Bashkova VA Med Parazitol (Mosk); 1995; (4):35-8. PubMed ID: 8587516 [TBL] [Abstract][Full Text] [Related]
12. Comparative vaccine efficacy of different isoforms of recombinant protective antigen against Bacillus anthracis spore challenge in rabbits. Ribot WJ; Powell BS; Ivins BE; Little SF; Johnson WM; Hoover TA; Norris SL; Adamovicz JJ; Friedlander AM; Andrews GP Vaccine; 2006 Apr; 24(17):3469-76. PubMed ID: 16519970 [TBL] [Abstract][Full Text] [Related]
13. Catalytically inactive anthrax toxin(s) are potential prophylactic agents. Gupta M; Alam S; Bhatnagar R Vaccine; 2007 Dec; 25(50):8410-9. PubMed ID: 17980467 [TBL] [Abstract][Full Text] [Related]
14. Expression and secretion of the protective antigen of Bacillus anthracis in Bacillus brevis. Rhie GE; Park YM; Chun JH; Yoo CK; Seong WK; Oh HB FEMS Immunol Med Microbiol; 2005 Aug; 45(2):331-9. PubMed ID: 16009541 [TBL] [Abstract][Full Text] [Related]
15. Western blot analysis of the exotoxin components from Bacillus anthracis separated by isoelectric focusing gel electrophoresis. Little SF Biochem Biophys Res Commun; 2004 Apr; 317(1):294-300. PubMed ID: 15047182 [TBL] [Abstract][Full Text] [Related]
16. The 2beta2-2beta3 loop of anthrax protective antigen contains a dominant neutralizing epitope. Zhang J; Xu J; Li G; Dong D; Song X; Guo Q; Zhao J; Fu L; Chen W Biochem Biophys Res Commun; 2006 Mar; 341(4):1164-71. PubMed ID: 16460675 [TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of immunodominant B-cell epitope of the C-terminus of protective antigen of Bacillus anthracis. Kaur M; Chug H; Singh H; Chandra S; Mishra M; Sharma M; Bhatnagar R Mol Immunol; 2009 Jun; 46(10):2107-15. PubMed ID: 19356802 [TBL] [Abstract][Full Text] [Related]
18. Single-step purification of recombinant anthrax lethal factor from periplasm of Escherichia coli. Chang HH; Tsai MF; Chung CP; Chen PK; Hu HI; Kau JH; Huang HH; Lin HC; Sun DS J Biotechnol; 2006 Nov; 126(3):277-85. PubMed ID: 16797097 [TBL] [Abstract][Full Text] [Related]
19. Immunogenicity of a subunit vaccine against Bacillus anthracis. Chichester JA; Musiychuk K; de la Rosa P; Horsey A; Stevenson N; Ugulava N; Rabindran S; Palmer GA; Mett V; Yusibov V Vaccine; 2007 Apr; 25(16):3111-4. PubMed ID: 17280756 [TBL] [Abstract][Full Text] [Related]
20. A recombinant 63-kDa form of Bacillus anthracis protective antigen produced in the yeast Saccharomyces cerevisiae provides protection in rabbit and primate inhalational challenge models of anthrax infection. Hepler RW; Kelly R; McNeely TB; Fan H; Losada MC; George HA; Woods A; Cope LD; Bansal A; Cook JC; Zang G; Cohen SL; Wei X; Keller PM; Leffel E; Joyce JG; Pitt L; Schultz LD; Jansen KU; Kurtz M Vaccine; 2006 Mar; 24(10):1501-14. PubMed ID: 16271808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]